Clincosm LogoSign in Get a demo

SOFA and APACHE II Scoring Systems for Predicting Outcome of Neurological Patients Admitted in a Tertiary Hospital Intensive Care Unit

Sponsor
Tribhuvan University Teaching Hospital, Institute Of Medicine. (Other)
Overall Status
Completed
CT.gov ID
NCT06111677
Collaborator
(none)
153
Enrollment
1
Location
4.6
Actual Duration (Months)
33.5
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The aim of this study was to compare the discriminative power of commonly used scoring systems, namely the sequential organ failure assessment (SOFA) and acute physiology and chronic health evaluation II (APACHE II) in the intensive care unit of a tertiary care hospital.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This was a retrospective cross-sectional study including patients admitted to the ICU of TU Teaching Hospital with a neurological diagnosis from January 1, 2022, to December 31, 2022. This study uses data collected prospectively as part of the Nepal Intensive Care Research Foundation (NICRF) dataset. The ICU database contained information for all components of the APACHE II and SOFA score with physiological data collected for the length of ICU, and hospital stay. Both SOFA and APACHE II were calculated from the admission data or if not available from the earliest data recorded after admission in ICUs.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    153 participants
    Observational Model:
    Other
    Time Perspective:
    Retrospective
    Official Title:
    SOFA and APACHE II Scoring Systems for Predicting Outcome of Neurological Patients Admitted in a Tertiary Hospital Intensive Care Unit
    Actual Study Start Date :
    Apr 15, 2023
    Actual Primary Completion Date :
    Aug 1, 2023
    Actual Study Completion Date :
    Sep 1, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Mortality [1 year]

      The outcome measure was ICU mortality (survivor vs non-survivor)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients admitted with neurological diagnosis in ICUs
    Exclusion Criteria:

    • Patients with missing data

    • Patients with ICU length of stay < 24 h

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Sumit Shahi Lalitpur Nepal 09771

    Sponsors and Collaborators

    • Tribhuvan University Teaching Hospital, Institute Of Medicine.

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Sumit Shahi, Principal Investigator, Tribhuvan University Teaching Hospital, Institute Of Medicine.
    ClinicalTrials.gov Identifier:
    NCT06111677
    Other Study ID Numbers:
    • NeurologicalOutcomeICU
    First Posted:
    Nov 1, 2023
    Last Update Posted:
    Nov 1, 2023
    Last Verified:
    Oct 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Nervous System Diseases

    Study Results

    No Results Posted as of Nov 1, 2023